The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fordyce Marshall since 2022.
This trader's CIK number is 1859453.
At the time of last reporting, Fordyce Marshall was the PRESIDENT AND CEO of Vera Therapeutics, Inc.. (stock ticker symbol VERA).
Also see all insider trading activities at Vera Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | VERA | 0 | $0 | 17,500 | $732,480 | 17,500 | $50,697 |
| 2024 | VERA | 0 | $0 | 165,721 | $7,187,814 | 222,427 | $640,446 |
| 2023 | VERA | 0 | $0 | 5,210 | $86,777 | 0 | $0 |
| 2022 | VERA | 0 | $0 | 42,891 | $886,333 | 238,350 | $633,813 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-08 | VERA | Option Ex | 17,500 | 2.90 | 50,697 |
| 2025-01-08 | VERA | Sale | 17,500 | 41.86 | 732,480 |
| 2024-12-18 | VERA | Sale | 17,500 | 43.01 | 752,622 |
| 2024-12-18 | VERA | Option Ex | 17,500 | 2.90 | 50,697 |
| 2024-12-19 | VERA | Option Ex | 57,661 | 2.90 | 167,043 |
| 2024-12-11 | VERA | Option Ex | 17,500 | 2.90 | 50,697 |
| 2024-12-11 | VERA | Sale | 17,500 | 47.26 | 827,102 |
| 2024-11-25 | VERA | Sale | 19,375 | 48.36 | 936,955 |
| 2024-11-25 | VERA | Option Ex | 19,375 | 2.90 | 56,129 |
| 2024-11-13 | VERA | Option Ex | 30,625 | 2.90 | 88,720 |
| 2024-11-13 | VERA | Sale | 30,625 | 49.84 | 1,526,319 |
| 2024-10-23 | VERA | Option Ex | 19,375 | 2.90 | 56,129 |
| 2024-10-23 | VERA | Sale | 19,375 | 41.03 | 794,956 |
| 2024-10-09 | VERA | Option Ex | 15,625 | 2.90 | 45,265 |
| 2024-10-09 | VERA | Sale | 15,625 | 38.46 | 600,906 |
| 2024-09-11 | VERA | Option Ex | 15,625 | 2.90 | 45,265 |
| 2024-09-11 | VERA | Sale | 15,625 | 37.54 | 586,609 |
| 2024-08-21 | VERA | Sale | 14,471 | 39.76 | 575,424 |
| 2024-08-14 | VERA | Option Ex | 15,625 | 2.90 | 45,265 |
| 2024-08-14 | VERA | Sale | 15,625 | 37.56 | 586,921 |
| 2023-12-29 | VERA | Option Ex | 13,516 | 2.61 | 35,236 |
| 2023-08-21 | VERA | Sale | 5,210 | 16.66 | 86,777 |
| 2022-11-16 | VERA | Option Ex | 65,153 | 2.61 | 169,853 |
| 2022-11-16 | VERA | Option Ex | 65,153 | 2.61 | 169,853 |
| 2022-11-16 | VERA | Option Ex | 65,153 | 2.61 | 169,853 |
| 2022-09-13 | VERA | Option Ex | 22,363 | 2.90 | 64,785 |
| 2022-09-13 | VERA | Sale | 22,363 | 21.13 | 472,530 |
| 2022-08-12 | VERA | Option Ex | 20,528 | 2.90 | 59,469 |
| 2022-08-12 | VERA | Sale | 20,528 | 20.16 | 413,803 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fordyce Marshall (PRESIDENT AND CEO of Vera Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.